Dow released thermal conductive structural adhesives for new energy vehicle batteries
Time of Update: 2022-11-25
On November 5, Dow unveiled the next-generation VORATRON MA for the new energy vehicle market at the 5th China International Import Expo The 8200S series elastic thermally conductive structural adhesive helps new energy vehicle battery packs meet the challenges of safety and durability, sustainability, and integrated assembly.
The end of 2022 is approaching, and pharmaceutical executives are leaving
Time of Update: 2022-10-25
On October 10, Hengrui Pharmaceutical announced that the company's board of directors recently received a resignation report from Tao Weikang, deputy general manager of the company, and after resigning from the above position due to personal reasons, Tao Weikang will no longer hold any position in the company.
Diab Group uses SABIC's PET modified material to produce fan blade core foam core material
Time of Update: 2022-08-26
. DIAB's family of Divinycell PY PET foamed cores, produced with SABIC's new LNP™ COLORCOMP™ compounds, enables designers to create innovative fan blades with longer lengths to meet high demands for precision, weight and quality consistency , The increasingly stringent industry standards .
The Chuxiong Prefecture Government and Desheng Group held a signing ceremony for the Yunnan Vanadium and Titanium Ecological Industrial Park Project
Time of Update: 2022-04-18
Desheng Group will promote the construction of the vanadium-titanium metal eco-industrial park project with high standards, high quality and high efficiency in a responsible attitude towards history, and strive to complete and put it into operation as soon as possible to help Yunnan Desheng’s green and low-carbon transformation and sustainable development .
Digitalization is coming, how do top pharmaceutical companies such as Merck, Pfizer, Sanofi, and Takeda come out on top in the competition
Time of Update: 2022-04-16
As an established pharmaceutical company, Pfizer has shown great enthusiasm for digital transformation, and has made attempts in AI+ drug research and development, big data, digital marketing, and patient services .
Hansen Announces Second Quarter 2020 Report: Total First Half Revenue of $1.45 Billion
Time of Update: 2020-10-05
The decline in sales in the second quarter of 2020 was the main reason for the decline in net sales, driven by the global economic impact of COVID-19 in various industries .
Sinda bio sindilimab decreased by more than 60% and was shortlisted in the national medical insurance
Time of Update: 2019-11-29
November 28, 2019 / Meitong news agency / -- Xinda biopharmaceutical (stock code of Hong Kong Stock Exchange: 01801), a biopharmaceutical company dedicated to the research and development, production